Bluetooth-Enabled Insulin Pen Receives FDA Clearance.

reports San Diego’s Companion Medical received FDA 510(k) clearance for its Bluetooth-enabled smart insulin pen and associated mobile app, called InPen. CEO Sean Saint said, “FDA clearance of the InPen and mobile app represents a significant advancement in diabetes care.” The device and app “can calculate and recommend optimal dosing, track history and timing of doses, monitor insulin temperature, display last dose and insulin-on-board, and report data to the user’s health care provider.” Eli Lilly, which has not in the past been involved with digital health, invested a reported $3 million in Companion Medical last year. http://mobihealthnews.com/content/lilly-backed-smartphone-enabled-insulin-pen-gets-fda-nod